# CEFDINIR

NDC: 72189-259
Generic name: CEFDINIR
Labeler / Manufacturer: DIRECT RX
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER, FOR SUSPENSION
Routes: ORAL
Marketing started: 20210913

FDA application: ANDA210534

## Active ingredients

- CEFDINIR: 250 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72189-259"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72189-259
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=982d0f53-20bc-1cb4-e053-2995a90ad33c